Skip to main content
. 2021 Apr 1;89(6):1240–1247. doi: 10.1002/ana.26063

TABLE 1.

Clinically Significant Pathogenic Mitochondrial DNA Variants Detected in the 11,424 Exomes Analyzed

Subject mtDNA variant Gene No. ref reads No. alt reads Het (%) Reported associated disease 9
1 m.3697G>A MT‐ND1 7 89 92 MELAS/LS/LDYT
2 m.8851T>C MT‐ATP6 1 61 98 BSN/LS
3 m.8993T>C MT‐ATP6 0 65 98 NARP/LS/MILS/other
4 m.9185T>C MT‐ATP6 1 76 97 LS/Ataxia syndromes/NARP‐like disease
5 m.9185T>C MT‐ATP6 7 96 92 LS/Ataxia syndromes/NARP‐like disease
6 m.10158T>C MT‐ND3 19 6 25 LS/MELAS
7 m.13094T>C MT‐ND5 87 55 39 Ataxia and PEO/MELAS, LS, myoclonus, fatigue
8 m.13513G>A MT‐ND5 47 54 53 LS/MELAS/LHON‐MELAS overlap syndrome
9 m.13513G>A MT‐ND5 19 3 14 LS/MELAS/LHON‐MELAS overlap syndrome
10 m.14459G>A MT‐ND6 1 83 96 LDYT/LS
11 m.14459G>A MT‐ND6 2 78 97 LDYT/LS

BSN = bilateral striatal necrosis; Het = heteroplasmy; LDYT = Leber hereditary optic neuropathy and dystonia; LHON = Leber hereditary optic neuropathy; LS = Leigh syndrome; MELAS = mitochondrial encephalomyopathy with lactic acidosis and stroke‐like episodes; MILS = maternally inherited Leigh syndrome; mtDNA = mitochondrial DNA; NARP = neurogenic muscle weakness, ataxia, and retinitis pigmentosa; PEO = progressive external ophthalmoplegia.